Inc. recently issued its prestigious list of America’s fastest growing private companies (Inc. 5000) and we are proud to announce that three of our partner…
Posted by
On the heels of continued IPO activity, there has been a flurry of media coverage — both positive and negative — regarding the companies that…
Posted by
At Safeguard Scientifics, we often talk about the importance of our partnerships with the life sciences and technology companies in which we deploy capital. There’s…
Posted by
Our partner company, Avid Radiopharmaceuticals, announced positive interim results from the Phase III clinical trial of its amyloid imaging agent Florbetapir F18 for early diagnosis…
Posted by
I frequently attribute Safeguard Scientifics’ success to our disciplined strategy built on five strategic themes, which we refer to as M2C3. We leverage these themes…
Posted by
Since coming to Safeguard Scientifics nearly five years ago, our management team created a game plan to transition our partner companies from a group of…
Posted by
In our report for the period ended Dec. 31, 2009 that was released this morning, we updated investors on the significant progress achieved by Safeguard…
Posted by
Hello, and welcome to the Safeguard Scientifics blog. The entire management team here is excited by the opportunities that this forum provides to enhance your…
Posted by
